Compound Detail
CHEMBL2011126
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL2011126 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | KDIZLZUNMOJKHK-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
1
PK Parameters
5
Publications
0
Known Names
Molecular Properties
459.6
MW (Da)
2.67
ALogP
7
HBA
1
HBD
94.6
PSA (Ų)
0.63
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 7.62
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| P2X purinoceptor 3 CHEMBL2998 | IC50 | 7.62 | 7.62 | 24.0 | 1 |
| Cytochrome P450 2C9 CHEMBL3397 | IC50 | 5.16 | 5.16 | 7000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 16.0 | mL.min-1.g-1 | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| P2X purinoceptor 3 | IC50 | = | 24.0 | nM | 7.62 | Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as in... | 22370269 |
| Cytochrome P450 2C9 | IC50 | = | 7000.0 | nM | 5.16 | Inhibition of recombinant CYP2C9 | 22370269 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22370269 | 10.1016/j.bmcl.2012.01.124 | P2X purinoceptor 3 | 1 |
| 22370269 | 10.1016/j.bmcl.2012.01.124 | No relevant target | 1 |
| 22370269 | 10.1016/j.bmcl.2012.01.124 | Cytochrome P450 2C9 | 1 |
| 22370269 | 10.1016/j.bmcl.2012.01.124 | Liver microsomes | 1 |
| 22370269 | 10.1016/j.bmcl.2012.01.124 | Caco-2 | 1 |
Data from ChEMBL 36 via Core Engine